Canine Hemangiosarcoma Cell Line (Grace-HSA)

Grace-HSA is a canine hemangiosarcoma cell line derived form a tumor in the spleen of an approximately 8-year old intact female Portuguese Water Dog.

Hemangiosarcoma is a rapidly growing, highly invasive variety of cancer, occurring commonly in dogs. It is a sarcoma arising from the lining of blood vessels. A frequent cause of death is the rupturing of this tumor, causing the patient to rapidly bleed to death.

From the laboratory of Jaime F. Modiano, VMD, PhD, University Minnesota, Twin Cities.

Catalog Number Product DataSheet Size AVAILABILITY Price Qty
EMN016-FP
Canine Hemangiosarcoma Cell Line (Grace-HSA)
1 vial In stock
Regular Price:$605.00
On Sale:

This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.

Specifications

Product Type: Cell Line
Name: Grace-HSA
Cell Type: Hemangiosarcoma
Source: Spleen
Organism: Dog
Morphology: Spindle
Biosafety Level: 2
Subculturing: Doubling time approx. 1 week, Split 1:3-1:5 when cells reach ~80% confluence.
Growth Conditions: Ham's F12, 10% FBS, 0.05mg/ml ECGS, 0.01mg/ml heparin, 10mM HEPES Buffer, 100ug/ml Primocin
Cryopreservation: 90%FBS/10% DMSO
Mycoplasma Tested: Yes
Storage: Liquid nitrogen
Shipped: Dry Ice

Provider
From the laboratory of Jaime F. Modiano, VMD, PhD, University Minnesota, Twin Cities.
References
  1. Borgatti, A., Duckett, M., Charles, S., & Modiano, J. F. (2014). Binding of VEGF-A to canine cancer cells with preferential expression of VEGFR1. Veterinary World, 7(1), 1-6. DOI: 10.14202/vetworld.2014.1-6

If you publish research with this product, please let us know so we can cite your paper.

Loading...